The purchase of Spectrum Plastics Group from AEA Investors by DuPont has been announced | The Healthcare Technology Report.
Summary
Spectrum Plastics has built a reputation for developing and manufacturing highly specialized medical components, including surgical instruments, implantable devices, and drug delivery systems. Rahul Goyal, a Partner at AEA Investors, has praised Spectrum Plastics for its best-in-class advanced manufacturing capabilities and multi-decade customer relationships with the world’s largest medical device OEMs. “Through investments in the commercial and engineering organizations and expansion of its manufacturing operations, Spectrum has enhanced its capabilities and offerings in medical end markets and achieved significant growth and increased profitability," he said. The combination of DuPont’s expertise in materials science and Spectrum Plastics’ advanced manufacturing capabilities will enable the development of cutting-edge medical products that address the industry’s most pressing needs. By leveraging Spectrum Plastics’ advanced manufacturing capabilities and customer relationships with the world’s largest medical device OEMs, DuPont will be well-positioned to meet the evolving needs of the healthcare market.